A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats

Drug and Chemical Toxicology

Volumn 32, Issue 2, 2009, Pages 128-138

  Kassa, Jiri ^a   Karasova, Jana ^a   Vasina, Libor ^a   Bajgar, Jiri ^a   Kuca, Kamil ^a,b   Musilek, Kamil ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Atropine; Functional observational battery; HI 6; K oximes; Obidoxime; Rats; Tabun

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ATROPINE; K 203; OBIDOXIME; OXIME DERIVATIVE; TABUN; TIPINDOLE METHIODIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; DISEASE MODELS, ANIMAL; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; OBIDOXIME CHLORIDE; ORGANOPHOSPHORUS COMPOUNDS; OXIMES; PHOSPHORIC ACID ESTERS; RATS; RATS, WISTAR;

RATTUS;

EID: 71049150798     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540802593873     Document Type: Article

References (27)

1. Cabal J, Bajgar J. (1999). Tabun-reappearance 50 years later (in Czech). Chem Listy 93:27-31.
2. Cabal J, Kuca K, Kassa J. (2004). Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol Toxicol 95:81-86.
3. Cassel G, Karlsson L, Waara L, Ang Wee K, Goransson-Nyberg A. (1997). Pharmacokinetics and effects of HI-6 in blood and brain of soman-intoxicated rats: A microdialysis study. Eur J Pharmacol 332:43-52.
4. Dawson RM. (1994). Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14:317-331.
5. Dohnal V, Kuca K, Jun D. (2005). Prediction of a new broad-spectrum reactivator capable of reactivating acetylcholinesterase inhibited by nerve agents. J Appl Toxicol 3:139-145.
6. Ekström F, Akfur C, Tunemalm AK, Lundberg S. (2006). Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 45:74-81.
7. Frantik E, Hornychova M. (1995). Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19-25.
8. Hornychova M, Frantik E, Kubat J, Formanek J. (1995). Neurotoxicity profile of supermethrin, a new pyrethroid insecticide. Cent Eur J Publ Health 3:210-218.
9. Jokanovic M. (1993). Anticholinesterase activity and delayed neurotoxic effects of tabun in hens. Vojvosanit Pregl 50:451-456.
10. Jokanovic M, Maksimovic M, Kilibarda V, Jovanovic D, Savic D. (1996). Oxime-induced reactivation of acetylcholinesterese inhibited by phosphoramidates. Toxicol Lett 85:35-39.
11. Kassa J. (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803-816.
12. Kassa J, Cabal J. (1999a). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111-118. (Pubitemid 29121949)
13. Kassa J, Cabal J. (1999b). A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 84:41-45. (Pubitemid 29069238)
14. Kassa J, Cabal J, Kuca K. (2005). A comparison of the efficacy of currently available oximes against tabun in rats. Biologia 60(Suppl 17):77-79.
15. Kassa J, Karasova J, Musilek K, Kuca K. (2008a). An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) with commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 243:311-316. (Pubitemid 350256870)
16. Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K. (2008b). A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium oximes (K206, K269) with currently available oximes against tabun in rats and mice. J Enz Inhib Med Chem 23:776-780.
17. Kassa J, Krejcova G. (2003). Neuroprotective effects of currently used antidotes in tabun-poisoned rats. Pharmacol Toxicol. 92:258-264.
18. Kassa J, Kuca K, Bartosova L, Kunesova G. (2007). The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 11:267-283.
19. Kuca K, Bielavsky J, Cabal J, Bielavska M. (2003a). Synthesis of a potential reactivator of acetylcholinesterase1-(4-hydroxyiminomethylpyridinium)- 3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett 44:3123-3125.
20. Kuca K, Bielavsky J, Cabal J, Kassa J. (2003b). Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 13:3545-3547.
21. Kuca K, Jun D, Musilek K. (2006). Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 6:269-277.
22. Marrs TC. (1993). Organophosphate poisoning. Pharmacol Ther 58:51-66.
23. Moser VC, Tilson H, McPhail RC, Becking GC, Cuomo V, Frantik E, Kulig BM, Winneke G. (1997). The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. NeuroToxicology 18:929-938. (Pubitemid 28087272)
24. Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Opletalova V, Dolezal M. (2008). Synthesis of mono-oxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun-and paraoxon-inhibited acetylcholinesterase. J Enz Inhib Med Chem 23:70-76.
25. Puu G, Artursson E, Bucht G. (1986). Reactivation of nerve agent-inhibited acetylcholinesterase by HI-6 and obidoxime. Biochem Pharmacol 35:1505-1510.
26. Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Toshibo M, Sakai I, Mukoyama H, Takatori T. (2003). Pralidoxime iodide (2-PAM) penetrates across the bloodbrain barrier. Neurochem Res 28:1401-1407.
27. Worek F, Widmann R, Knopff O, Szinicz L. (1998). Reactivating potency of obidoxime, pralidoxime, HI-6, and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72:237-243.